WPA
CASI

West Paces Advisors’s CASI Pharmaceuticals CASI Stock Holding History

West Paces Advisors’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$216 – 263
2025
Q1 		$216 Hold
100
– – ﹤0.01% 549
2024
Q4 		$283 Hold
100
– – ﹤0.01% 538
2024
Q3 		$616 Hold
100
– – ﹤0.01% 507
2024
Q2 		$550 Hold
100
– – ﹤0.01% 528
2024
Q1 		$361 Hold
100
– – ﹤0.01% 558
2023
Q4 		$716 Hold
100
– – ﹤0.01% 530
2023
Q3 		$256 Hold
100
– – ﹤0.01% 509
2023
Q2 		$250 Hold
100
– – ﹤0.01% 535
2023
Q1 		$232 Hold
100
– – ﹤0.01% 547
2022
Q4 		$179 Buy
+100
New +$198 ﹤0.01% 525

Other funds holding CASI

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return